Overexpression of Rififylin is a Genetically Determined Risk Factor Linked to Aberrant Cardiomyocyte Function, QT Interval and Hypertension Article (Faculty180)

cited authors

  • Gopalakrishnan, K.; Morgan, E.; Kumarasamy, S.; Yerga-Woolwine, S .; Farms, P.; Kalinoski, A.; Liu, L. J.; Joe, B. N.

authors

publication date

  • 2010

published in

start page

  • E94

end page

  • E94

volume

  • 56